background image

Follicular Lymphoma Clinical Trials

Find clinical trials for follicular lymphoma. Search for follicular lymphoma clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

64Cu-LLP2A for Imaging Hematologic Malignancies

for
Multiple Myeloma, Low-Grade Lymphoma, Follicular Lymphoma,
Location: 1 recruiting location
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06636175

Early_phase1, Recruiting
Active & Responsive

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

for
Follicular Lymphoma, Mantle Cell Lymphoma, Hairy Cell Leukemia,
Location: 1 recruiting location
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT06340737

Phase1, Recruiting
Active & Responsive

Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma

for
Follicular Lymphoma, Marginal Zone Lymphoma, B-cell Lymphoma
Location: 2 recruiting locations
Sponsor: Brown University

Sex: All

Age: 18+

Code: NCT04792502

Phase2, Recruiting
Active & Responsive

SynKIR-310 for Relapsed/Refractory B-NHL

for
B Cell Lymphoma, NHL, Adult, Mantle Cell Lymphoma,
Location: 4 recruiting locations
Sponsor: Verismo Therapeutics

Sex: All

Age: 18+

Code: NCT06544265

Phase1, Recruiting
Active & Responsive

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

for
Metastatic Castration Resistant Prostate Cancer (mCRPC),
Location: 13 recruiting locations
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT03460977

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

for
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma,
Location: 16 recruiting locations
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05458297

Phase2, Recruiting
Active & Responsive

Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL

for
DLBCL, Diffuse Large B Cell Lymphoma,
Location: 1 recruiting location
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT04855253

Phase1, Phase2, Recruiting
Active & Responsive

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

for
Neuroendocrine Tumors, Neuroendocrine Tumor Grade 1,
Location: 1 recruiting location
Sponsor: University of Iowa

Sex: All

Age: 18+

Code: NCT06395402

Phase2, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

for
Lymphoma, Follicular
Location: 17 recruiting locations
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT06425302

Phase2, Recruiting
Active & Responsive

Safusidenib Phase 2 Study in IDH1 Mutant Glioma

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: 21 recruiting locations
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase2, Recruiting